<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7356962\results\search\virus\results.xml">
  <result pre="periodic cold or mild human digestive infections [3]. A new" exact="human coronavirus" post="(CoV) became notably popular in spring 2003 because of"/>
  <result pre="of medicinal plants or isolated compounds on different strains of" exact="human coronavirus." post="Among these, four extracts exhibited moderate to potent inhibition"/>
  <result pre="of CoV that infects humans and animals and together with" exact="human coronavirus" post="OC43 is one of the common-cold viruses [17]. Such"/>
  <result pre="the treatment of SARSPhytother. Res.20041859259410.1002/ptr.148515305324 17.ChengP.W.NgL.T.ChiangL.C.LinC.C.Antiviral effects of saikosaponins on" exact="human coronavirus" post="229E in vitroClin. Experim. Pharmacol. Physiol.20063361261610.1111/j.1440-1681.2006.04415.x 18.HoeverG.BaltinaL.MichaelisM.KondratenkoR.BaltinaL.TolstikovG.A.CinatlJ.Antiviral Activity of"/>
  <result pre="Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against" exact="human coronavirus" post="NL63Virus. Res.201927319776710.1016/j.virusres.2019.19776731560964 59.Oâ€™KeefeB.R.GiomarelliB.BarnardD.L.ShenoyS.R.ChanP.K.McMahonJ.B.McCrayP.B.Broad-spectrum in vitro activity and in vivo"/>
  <result pre="B: Trends and developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity against" exact="human immunodeficiency virus" post="type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically"/>
 </snippets>
</snippetsTree>
